BiotechTube

Trabectedin

Pre-clinicalCompleted
0 watching 0 views this week💤 Quiet
23
Hype Score

Development Stage

1
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Soft Tissue Sarcoma

Conditions

Soft Tissue Sarcoma

Trial Timeline

— → —

NCT ID
NCT01427582

About Trabectedin

Trabectedin is a pre-clinical stage product being developed by Johnson & Johnson for Soft Tissue Sarcoma. The current trial status is completed. This product is registered under clinical trial identifier NCT01427582. Target conditions include Soft Tissue Sarcoma.

Hype Score Breakdown

Clinical
5
Activity
2
Company
10
Novelty
2
Community
1

Clinical Trials (2)

NCT IDPhaseStatus
NCT01427582Pre-clinicalCompleted
NCT00072670Phase 2Completed

Competing Products

20 competing products in Soft Tissue Sarcoma

See all competitors
ProductCompanyStageHype Score
Olaratumab + Doxorubicin + Ifosfamide + MesnaEli LillyPhase 1
33
Anlotinib HydrochlorideSun PharmaceuticalPhase 2
52
Eribulin mesylate 1.4 mg/m^2 intravenous + Dacarbazine of 850 mg/m^2, or 1,000 mg/m^2, or 1,200 mg/m^2 IVEisaiPhase 3
77
Eribulin mesylateEisaiPre-clinical
23
E7389EisaiPhase 2
52
eribulin mesylateEisaiPhase 2
52
Olaratumab + Gemcitabine + Docetaxel + PlaceboEli LillyPhase 1/2
41
LY573636-sodiumEli LillyPhase 2
52
OlaratumabEli LillyPre-clinical
23
Olaratumab + Doxorubicin + PlaceboEli LillyPhase 3
77
Olaratumab + DoxorubicinEli LillyPhase 1
33
Olaratumab + DoxorubicinEli LillyPhase 1
33
Olaratumab + Pembrolizumab (KEYTRUDA®)Eli LillyPhase 1
33
Olaratumab + doxorubicinEli LillyPhase 1/2
41
Doxorubicin + Trabectedin + DexamethasoneJohnson & JohnsonPhase 1
33
Apatinib Mesylate, doxorubicin, ifosfamideJiangsu Hengrui MedicinePhase 2
52
Camrelizumab in Combination With Neoadjuvant ChemotherapyJiangsu Hengrui MedicinePhase 2
52
Durvalumab and Tremelimumab + DoxorubicinAstraZenecaPhase 2
52
Standard arm: Trabectedin in monotherapy + Experimental arm: Trabectedin + OlaparibAstraZenecaPhase 2
52
trabectedin + olaparibAstraZenecaPhase 1
33

Other Products from Johnson & Johnson

Fentanyl transdermal therapeutic systemApproved
85
Nicotine Gum + Nicotine PatchApproved
85
galantamineApproved
85
IbrutinibApproved
85
Paliperidone ERApproved
85